Walgreens Boots Alliance (WBA) Stock
Consumer staples company. Here's the price, business snapshot, and what's worth knowing about Walgreens Boots Alliance in August 2026.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest maintaining Walgreens Boots stock, with a target price of $13.71 indicating potential growth.
Financial Health
Walgreens Boots Alliance is generating stable revenue and cash flow, but profit margins are relatively low.
Dividend
Walgreens Boots Alliance's high dividend yield of 8.73% is appealing for those seeking dividend income. If you invested $1000 you would be paid $87.30 a year in dividends (based on the last 12 months).
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.